Effects of ivabradine and ranolazine in patients with microvascular angina pectoris. 2013

Angelo Villano, and Antonino Di Franco, and Roberto Nerla, and Alfonso Sestito, and Pierpaolo Tarzia, and Priscilla Lamendola, and Antonio Di Monaco, and Filippo Maria Sarullo, and Gaetano Antonio Lanza, and Filippo Crea
Department of Cardiovascular Medicine, Università Cattolica del Sacro Cuore, Roma, Italy.

Patients with microvascular angina (MVA) often have persistence of symptoms despite full classical anti-ischemic therapy. In this study, we assessed the effect of ivabradine and ranolazine in MVA patients. We randomized 46 patients with stable MVA (effort angina, positive exercise stress test [EST], normal coronary angiography, coronary flow reserve <2.5), who had symptoms inadequately controlled by standard anti-ischemic therapy, to ivabradine (5 mg twice daily), ranolazine (375 mg twice daily), or placebo for 4 weeks. The Seattle Angina Questionnaire (SAQ), EuroQoL scale, and EST were assessed at baseline and after treatment. Coronary microvascular dilation in response to adenosine and to cold pressor test and peripheral endothelial function (by flow-mediated dilation) were also assessed. Both drugs improved SAQ items and EuroQoL scale compared with placebo (p <0.01 for all), with ranolazine showing some more significant effects compared with ivabradine, on some SAQ items and EuroQoL scale (p <0.05). Time to 1-mm ST-segment depression and EST duration were improved by ranolazine compared with placebo. No effects on coronary microvascular function and on flow-mediated dilation were observed with drugs or placebo. In conclusion, ranolazine and ivabradine may have a therapeutic role in MVA patients with inadequate control of symptoms in combination with usual anti-ischemic therapy.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D011788 Quality of Life A generic concept reflecting concern with the modification and enhancement of life attributes, e.g., physical, political, moral, social environment as well as health and disease. HRQOL,Health-Related Quality Of Life,Life Quality,Health Related Quality Of Life
D011795 Surveys and Questionnaires Collections of data obtained from voluntary subjects. The information usually takes the form of answers to questions, or suggestions. Community Survey,Nonrespondent,Questionnaire,Questionnaires,Respondent,Survey,Survey Method,Survey Methods,Surveys,Baseline Survey,Community Surveys,Methodology, Survey,Nonrespondents,Questionnaire Design,Randomized Response Technique,Repeated Rounds of Survey,Respondents,Survey Methodology,Baseline Surveys,Design, Questionnaire,Designs, Questionnaire,Methods, Survey,Questionnaire Designs,Questionnaires and Surveys,Randomized Response Techniques,Response Technique, Randomized,Response Techniques, Randomized,Survey, Baseline,Survey, Community,Surveys, Baseline,Surveys, Community,Techniques, Randomized Response
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D005080 Exercise Test Controlled physical activity which is performed in order to allow assessment of physiological functions, particularly cardiovascular and pulmonary, but also aerobic capacity. Maximal (most intense) exercise is usually required but submaximal exercise is also used. Arm Ergometry Test,Bicycle Ergometry Test,Cardiopulmonary Exercise Testing,Exercise Testing,Step Test,Stress Test,Treadmill Test,Cardiopulmonary Exercise Test,EuroFit Tests,Eurofit Test Battery,European Fitness Testing Battery,Fitness Testing,Physical Fitness Testing,Arm Ergometry Tests,Bicycle Ergometry Tests,Cardiopulmonary Exercise Tests,Ergometry Test, Arm,Ergometry Test, Bicycle,Ergometry Tests, Arm,Ergometry Tests, Bicycle,EuroFit Test,Eurofit Test Batteries,Exercise Test, Cardiopulmonary,Exercise Testing, Cardiopulmonary,Exercise Tests,Exercise Tests, Cardiopulmonary,Fitness Testing, Physical,Fitness Testings,Step Tests,Stress Tests,Test Battery, Eurofit,Test, Arm Ergometry,Test, Bicycle Ergometry,Test, Cardiopulmonary Exercise,Test, EuroFit,Test, Exercise,Test, Step,Test, Stress,Test, Treadmill,Testing, Cardiopulmonary Exercise,Testing, Exercise,Testing, Fitness,Testing, Physical Fitness,Tests, Arm Ergometry,Tests, Bicycle Ergometry,Tests, Cardiopulmonary Exercise,Tests, EuroFit,Tests, Exercise,Tests, Step,Tests, Stress,Tests, Treadmill,Treadmill Tests
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Angelo Villano, and Antonino Di Franco, and Roberto Nerla, and Alfonso Sestito, and Pierpaolo Tarzia, and Priscilla Lamendola, and Antonio Di Monaco, and Filippo Maria Sarullo, and Gaetano Antonio Lanza, and Filippo Crea
January 2013, Journal of pharmacology & pharmacotherapeutics,
Angelo Villano, and Antonino Di Franco, and Roberto Nerla, and Alfonso Sestito, and Pierpaolo Tarzia, and Priscilla Lamendola, and Antonio Di Monaco, and Filippo Maria Sarullo, and Gaetano Antonio Lanza, and Filippo Crea
January 2014, Cardiology,
Angelo Villano, and Antonino Di Franco, and Roberto Nerla, and Alfonso Sestito, and Pierpaolo Tarzia, and Priscilla Lamendola, and Antonio Di Monaco, and Filippo Maria Sarullo, and Gaetano Antonio Lanza, and Filippo Crea
March 2006, Drugs of today (Barcelona, Spain : 1998),
Angelo Villano, and Antonino Di Franco, and Roberto Nerla, and Alfonso Sestito, and Pierpaolo Tarzia, and Priscilla Lamendola, and Antonio Di Monaco, and Filippo Maria Sarullo, and Gaetano Antonio Lanza, and Filippo Crea
February 2017, The Cochrane database of systematic reviews,
Angelo Villano, and Antonino Di Franco, and Roberto Nerla, and Alfonso Sestito, and Pierpaolo Tarzia, and Priscilla Lamendola, and Antonio Di Monaco, and Filippo Maria Sarullo, and Gaetano Antonio Lanza, and Filippo Crea
January 2011, American journal of cardiovascular drugs : drugs, devices, and other interventions,
Angelo Villano, and Antonino Di Franco, and Roberto Nerla, and Alfonso Sestito, and Pierpaolo Tarzia, and Priscilla Lamendola, and Antonio Di Monaco, and Filippo Maria Sarullo, and Gaetano Antonio Lanza, and Filippo Crea
May 2009, Nature reviews. Cardiology,
Angelo Villano, and Antonino Di Franco, and Roberto Nerla, and Alfonso Sestito, and Pierpaolo Tarzia, and Priscilla Lamendola, and Antonio Di Monaco, and Filippo Maria Sarullo, and Gaetano Antonio Lanza, and Filippo Crea
January 2017, Cardiology,
Angelo Villano, and Antonino Di Franco, and Roberto Nerla, and Alfonso Sestito, and Pierpaolo Tarzia, and Priscilla Lamendola, and Antonio Di Monaco, and Filippo Maria Sarullo, and Gaetano Antonio Lanza, and Filippo Crea
November 2006, Ugeskrift for laeger,
Angelo Villano, and Antonino Di Franco, and Roberto Nerla, and Alfonso Sestito, and Pierpaolo Tarzia, and Priscilla Lamendola, and Antonio Di Monaco, and Filippo Maria Sarullo, and Gaetano Antonio Lanza, and Filippo Crea
June 2011, MMW Fortschritte der Medizin,
Angelo Villano, and Antonino Di Franco, and Roberto Nerla, and Alfonso Sestito, and Pierpaolo Tarzia, and Priscilla Lamendola, and Antonio Di Monaco, and Filippo Maria Sarullo, and Gaetano Antonio Lanza, and Filippo Crea
April 2016, Medicine,
Copied contents to your clipboard!